by Howard Fencl, Hennes Communications
Very soon, likely now within weeks, executive leadership across every single market sector will be confronted by a dramatic change in the way they are currently managing their office response to COVID-19. Because of past inconsistent – and often contradictory – advice coming from a wide variety of social media outlets, as well as from federal, state and local elected officials along with medical advice that changes based on the latest research, business leaders will have to quickly sort truth from fiction along with mastering the rudiments of epidemiology.
The next pandemic-related surge is about to confront us all. It’ll be a surge of lies, misinformation and disinformation about the imminent COVID-19 vaccine. Expect it to come at us in warp speed over the coming days and weeks.
On November 9, Pfizer and its German partner, BioNTech, announced that the vaccine they’ve developed and tested in phase 3 clinical trials is more than 90% effective protecting people from COVID-19 infection. A week later, Moderna announced its vaccine, reporting 94.5% efficacy. With fast-track FDA approval, tens of millions of doses could be available before the year ends.
With one out of five Americans already saying they won’t take the vaccine, the communication challenge for the U.S. government and the health care community is a monumental one. Public health officials have called it “a train wreck waiting to happen.”
The Centers for Disease Control and Prevention (CDC), always the country’s go-to source for health crisis information, was minimized by the White House – its voice subsumed by the new government task force Operation Warp Speed and the Department of Health and Human Services (HHS). The outgoing administration continues to politicize the issue:
Anti-vaxxers and conspiracy theorists continue finding ways to communicate doubt and falsehoods on social media platforms. And while Facebook, Twitter and YouTube have beefed up their policies about posting misinformation, their social media algorithms keep pushing zealot views to like-minded followers, confirming those beliefs. Adding to that, other pharma players – including Johnson & Johnson and AstraZeneca – are joining Pfizer/BioNTech, Moderna with the development of their own vaccines, additional misinformation risks loom.
In a perfect world, U.S., state and local governments, pharma companies and health care organizations should speak with one voice in an aggressive, proactive, ongoing public health information campaign to educate the American public about the vaccine. Designate a lead organization and speak about the vaccine across all communication platforms – including the media – every day. Explain how vaccines are developed. How the vaccine developers were able to speed up their breakthroughs without compromising patient safety. How the vaccine will be made available and the likely order of people who will receive it. Explain the vaccine’s efficacy and risks honestly. Recruit spokesperson ambassadors from entertainment, sports, academia, religious and community organizations to help spread the word. Then explain it all again.
Messaging must be consistent transparent and truthful. Messaging can’t pivot on “get the vaccine and voila! Everyone’s life is back to normal!” The vaccine jab sounds like it’ll hurt and it’ll initially make you feel sick. Dr. William Schaffner, a vaccine expert and professor of infectious diseases at Vanderbilt University, told USA Today, “This is a nasty vaccine to get. It really makes your arm sore. It can make you feel crummy for 24 hours. And remember, it’s a two-dose vaccine. Well, guess what – the second dose is worse than the first.”
Can you expect to win everyone over with a pervasive public health information campaign? No. A third of the campaign’s audience will buy into it, a third will be on the fence, and a third will continue to be outraged. Noted risk management expert Peter Sandman writes that the most coordinated communication effort may not change the minds of angry or frightened people, but you should work to find middle ground:
Backlash against vaccines in the U.S. is almost as old as the country itself, from opposition to smallpox vaccines in the 19th century to controversy over tuberculosis, polio, DPT MMR and HPV vaccines in more recent times. Supercharged by the megaphone social media provides, those opposed to a COVID-19 vaccine pose a formidable challenge that executive leadership and communicators must meet head-on.
Hennes Communications is one of the few firms in N. America focused exclusively on crisis communications and crisis management. Based in Cleveland, Ohio, the firm serves corporations, government agencies, schools, hospitals and adult-care communities, along with bar associations, law firms and their clients, that are “on trial” in the Court of Public Opinion, Hennes Communications also offers litigation communication support, media training, pre-crisis preparation and crisis drills to clients.
ABOUT THE AUTHOR